AngioDynamics Inc
NASDAQ:ANGO
Intrinsic Value
AngioDynamics, Inc. is a medical device company, which engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. [ Read More ]
The intrinsic value of one ANGO stock under the Base Case scenario is 16.17 USD. Compared to the current market price of 5.87 USD, AngioDynamics Inc is Undervalued by 64%.
Valuation Backtest
AngioDynamics Inc
Run backtest to discover the historical profit from buying and selling ANGO stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Our AI Assistant is coming soon! Stay tuned and thank you for your interest!
Provide an overview
of AngioDynamics Inc's business.
What risks and challenges
does AngioDynamics Inc face in the near future?
Summarize the latest earnings report
of AngioDynamics Inc.
Provide P/E
for AngioDynamics Inc and its competitors.
Balance Sheet Decomposition
AngioDynamics Inc
Current Assets | 185.5m |
Cash & Short-Term Investments | 60.9m |
Receivables | 51.6m |
Other Current Assets | 73m |
Non-Current Assets | 314.2m |
PP&E | 42.6m |
Intangibles | 263.1m |
Other Non-Current Assets | 8.5m |
Current Liabilities | 78m |
Accounts Payable | 37.7m |
Accrued Liabilities | 29.2m |
Other Current Liabilities | 11.2m |
Non-Current Liabilities | 20.4m |
Other Non-Current Liabilities | 20.4m |
Earnings Waterfall
AngioDynamics Inc
Revenue
|
329.5m
USD
|
Cost of Revenue
|
-162.4m
USD
|
Gross Profit
|
167.2m
USD
|
Operating Expenses
|
-191.9m
USD
|
Operating Income
|
-24.8m
USD
|
Other Expenses
|
10.6m
USD
|
Net Income
|
-14.1m
USD
|
Free Cash Flow Analysis
AngioDynamics Inc
What is Free Cash Flow?
ANGO Profitability Score
Profitability Due Diligence
AngioDynamics Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.
Score
AngioDynamics Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.
ANGO Solvency Score
Solvency Due Diligence
AngioDynamics Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.
Score
AngioDynamics Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ANGO Price Targets Summary
AngioDynamics Inc
According to Wall Street analysts, the average 1-year price target for ANGO is 14.28 USD with a low forecast of 10.1 USD and a high forecast of 18.9 USD.
Ownership
ANGO Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
ANGO Price
AngioDynamics Inc
Average Annual Return | 0.29% |
Standard Deviation of Annual Returns | 62.55% |
Max Drawdown | -83% |
Market Capitalization | 233.9m USD |
Shares Outstanding | 40 219 000 |
Percentage of Shares Shorted | 7.4% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
AngioDynamics, Inc. is a medical device company, which engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The company is headquartered in Latham, New York and currently employs 800 full-time employees. The company went IPO on 2004-05-27. Its devices are used in minimally invasive, image-guided procedures. Its product offerings include Endovascular Therapies, Oncology/Surgery (OS) and Vascular Access (VA). Its Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products (Core) and Venous Insufficiency. Its OS product offerings includes a range of ablation technologies, including thermal tissue ablation systems, surgical resection and the Irreversible Electroporation (IRE) technology, the NanoKnife System. Its portfolio of VA products includes peripherally inserted central catheters (PICCs), midline catheters, implantable ports, dialysis catheters and related accessories and supplies.
Contact
IPO
Employees
Officers
The intrinsic value of one ANGO stock under the Base Case scenario is 16.17 USD.
Compared to the current market price of 5.87 USD, AngioDynamics Inc is Undervalued by 64%.